X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Cardiology in Review

期刊標題檢索 CARDIOL REV 最新評論: Fellow authors, the review process is fast, isn't it? (2023-07-24)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Cardiology in Review]您好,您是該頁面的第 11496 位訪客。

期刊簡介
期刊名稱Cardiology in Review Cardiology in Review
LetPub Score
5.1
50 ratings
Rate

Reputation
6.4

Influence
3.7

Speed
7.0

期刊簡稱CARDIOL REV
ISSN1061-5377
E-ISSN1538-4683
h-index51
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.600.5980.677
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Cardiology and Cardiovascular Medicine
Q2132 / 387

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
The mission of Cardiology in Review is to publish reviews on topics of current interest in cardiology that will foster increased understanding of the pathogenesis, diagnosis, clinical course, prevention, and treatment of cardiovascular disorders. Articles of the highest quality are written by authorities in the field and published promptly in a readable format with visual appeal
官方網站http://journals.lww.com/cardiologyinreview/pages/default.aspx
在線稿件提交https://www.editorialmanager.com/CIR
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域CARDIAC & CARDIOVASCULAR SYSTEMS
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年1993
每年文章數46每年文章數趨勢
黃金OA百分比4.35%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ3118/220
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1061-5377%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Cardiology in Review】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645708
    BIOMATERIALS601296
    Frontiers in Pharmacology503183
    BIOMEDICINE & PHARMACOTHERAPY498659
    JOURNAL OF ETHNOPHARMACOLOGY495349
    Journal of Materials Chemistry B476181
    Frontiers in Immunology461414
    COMPUTERS IN BIOLOGY AND MEDICINE420478
    COLLOIDS AND SURFACES B-BIOINTERFACES419542
    Frontiers in Oncology415879
  •  

    Cardiology in Review Cardiology in Review
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Cardiology in Review] 的評論撰寫評論
作者: 雾都含芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-24 15:12:38 評論於
Fellow authors, the review process is fast, isn't it?
(0) 讚! | 雾都含芙

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:02:30 評論於
The abstract of a paper helps readers connect all the different parts of the paper, so it is important to avoid too many detailed descriptions
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:13:20 評論於
Each sentence in the abstract should provide maximum information as concisely as possible. The length of the abstract generally does not exceed 300 words. The beginning of the abstract should present the most important information (but not repeat the title). It can be the purpose or topic, as well as the result or conclusion. The abstract should include no more than 4 or 5 of the most important points, results, or implications
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:45:12 評論於
How can I make reviewers understand my research just by reading the abstract?
(0) 讚! | 上清雨真

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 15:02:09 評論於
How to reduce the abstract to the required word count by the journal? Which part should be deleted?
(0) 讚! | 破戒阳平

作者: 是绮艳吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-19 23:53:56 評論於
Review speed: 6.0 Experience sharing: Submitted a review article, under review for 4 months, ultimately rejected, stating that my writing was too complex for the reviewers to make a decision
(0) 讚! | 是绮艳吖

作者: 是绮艳吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-19 13:21:34 評論於
My paper was rejected after four months of review
(0) 讚! | 是绮艳吖

作者: 沛容氏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-19 11:43:23 評論於
I got a desk reject, yours should have been reviewed externally
(0) 讚! | 沛容氏

作者: 沛容氏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-16 13:56:37 評論於
Refusal to return in 2 days
(0) 讚! | 沛容氏

作者: 是你的屠维呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-07 12:37:53 評論於
This is the first time I found this magazine. Does the magazine specialize in reviews?
(0) 讚! | 是你的屠维呀

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 21:56:32 評論於
Although there haven't been any major changes this year, we'll see what happens in the future
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 21:25:05 評論於
Can we score 3 points next year? Let's discuss
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 20:50:47 評論於
Bullish, it is expected to break through 3 points if it rises again tomorrow
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Cardiology in Review] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*